Cargando…
Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment
Coronavirus disease (COVID-19) is caused by SARS-COV2 and has resulted in more than four million cases globally and the death cases exceeded 300,000. Normally, a range of surviving and propagating host factors must be employed for the completion of the infectious process including RPs. Viral protein...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834321/ https://www.ncbi.nlm.nih.gov/pubmed/32502901 http://dx.doi.org/10.1016/j.mehy.2020.109904 |